Recruiting Thalassemia Studies in Los Angeles
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the t...
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
This is a Phase 2a study to evaluate the safety and pharmacokinetics (PK) of luspatercept in pediatric participants with β-thalassemia. The study will be conducted in 2 parts for both transfusion-dep...
About Thalassemia Clinical Trials in Los Angeles
Thalassemia is an inherited blood disorder causing the body to produce abnormal or insufficient hemoglobin. Severe forms (thalassemia major) require regular blood transfusions. Treatment includes transfusions, iron chelation therapy, and potentially curative gene therapy.
There are currently 2 thalassemia clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 764 participants. Research is being sponsored by Celgene. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thalassemia Clinical Trials in Los Angeles — FAQ
Are there thalassemia clinical trials in Los Angeles?
Yes, there are 2 thalassemia clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What thalassemia treatments are being tested?
The 2 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for thalassemia.
Data updated March 2, 2026 from ClinicalTrials.gov